The proposed budget for the Department of Health and Human Services slashes CDC and NIH funding in favor of the new ...

The U.S. Food and Drug Administration on Thursday expanded the use of Moderna's respiratory syncytial virus vaccine to a ...

The global respiratory syncytial virus respiratory syncytial virus treatment market is undergoing rapid growth, driven by rising vaccine uptake, impr ...

Researchers laid off in April were putting the finishing touches on in-depth HIV surveys that guide treatment and prevention.

Dr. Mark Sawyer says recent changes to the Centers for Disease Control and Prevention’s vaccine advisory committee could ...

MPV tends to hit hardest in young children, older adults and people with weakened immune systems. A virologist explains.

As winter settles over Australia, it's not just the drop in temperature we notice—there's also a sharp rise in respiratory ...

The medication, Lenacapavir, is said to have shown exceptional promise in clinical trials, and some of the research is being conducted here in Houston.

The FDA expanded the approval of the direct-acting antiviral (DAA) glecaprevir/pibrentasvir (Mavyret), making it the first ...

Following recent hantavirus cases, the Nevada Department of Health and Human Services and Nevada Department of Wildlife are urging Nevadans to exercise caution against the disease.

It scares me to think of what’s ahead,” said Michael Osterholm, director of the University of Minnesota’s Center for ...